Literature DB >> 18303244

Linkage of pluripotent stem cell-associated transcripts to regulatory gene networks.

Kirill V Tarasov1, Gianluca Testa, Yelena S Tarasova, Gabriela Kania, Daniel R Riordon, Maria Volkova, Sergey V Anisimov, Anna M Wobus, Kenneth R Boheler.   

Abstract

Knowledge of the transcriptional circuitry responsible for pluripotentiality and self-renewal in embryonic stem cells is tantamount to understanding early mammalian development and a prerequisite to determining their therapeutic potential. Various techniques have employed genomics to identify transcripts that were abundant in stem cells, in an attempt to define the molecular basis of 'stemness'. In this study, we have extended traditional genomic analyses to identify cis-elements that might be implicated in the control of embryonic stem cell-restricted gene promoters. The strategy relied on the generation of a problem-specific list from serial analysis of gene expression profiles and subsequent promoter analyses to identify frameworks of multiple cis-elements conserved in space and orientation among genes from the problem-specific list. Subsequent experimental data suggest that 2 novel transcription factors, B-Myb and Maz, predicted from these models, are implicated either in the maintenance of the undifferentiated stem cell state or in early steps of differentiation. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303244     DOI: 10.1159/000118787

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  8 in total

1.  Banf1 is required to maintain the self-renewal of both mouse and human embryonic stem cells.

Authors:  Jesse L Cox; Sunil K Mallanna; Briana D Ormsbee; Michelle Desler; Matthew S Wiebe; Angie Rizzino
Journal:  J Cell Sci       Date:  2011-07-12       Impact factor: 5.285

Review 2.  Stem cell pluripotency: a cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle.

Authors:  Kenneth R Boheler
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

3.  Mybl2, downregulated during colon epithelial cell maturation, is suppressed by miR-365.

Authors:  Michael Papetti; Leonard H Augenlicht
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-07-07       Impact factor: 4.052

4.  MYBL2, a link between proliferation and differentiation in maturing colon epithelial cells.

Authors:  Michael Papetti; Leonard H Augenlicht
Journal:  J Cell Physiol       Date:  2011-03       Impact factor: 6.384

5.  The role of MYB proto-oncogene like 2 in tamoxifen resistance in breast cancer.

Authors:  Xia Li; Xi Zhang; Cong-Cong Wu; Ping-Ping Li; Yi-Mou Fu; Li-Hua Xie; Shuang-Shuang Sun; Ying-Ying Zhou; Bao-Ling Zhu
Journal:  J Mol Histol       Date:  2020-11-03       Impact factor: 2.611

6.  The B-MYB transcriptional network guides cell cycle progression and fate decisions to sustain self-renewal and the identity of pluripotent stem cells.

Authors:  Ming Zhan; Daniel R Riordon; Bin Yan; Yelena S Tarasova; Sarah Bruweleit; Kirill V Tarasov; Ronald A Li; Robert P Wersto; Kenneth R Boheler
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

Review 7.  MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.

Authors:  Julian Musa; Marie-Ming Aynaud; Olivier Mirabeau; Olivier Delattre; Thomas Gp Grünewald
Journal:  Cell Death Dis       Date:  2017-06-22       Impact factor: 8.469

8.  B-MYB is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells.

Authors:  Kirill V Tarasov; Yelena S Tarasova; Wai Leong Tam; Daniel R Riordon; Steven T Elliott; Gabriela Kania; Jinliang Li; Satoshi Yamanaka; David G Crider; Gianluca Testa; Ronald A Li; Bing Lim; Colin L Stewart; Yie Liu; Jennifer E Van Eyk; Robert P Wersto; Anna M Wobus; Kenneth R Boheler
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.